Latest Conference Articles

Checkout some of the most important sessions and video interviews from the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo.

Erin Rexroth, director of marketing at NCPA, discusses how smaller pharmacies can compete with large chains when it comes to digital marketing.

A conversation with Lauren Angelo, PharmD, MBA, associate dean of academic affairs and an associate professor of pharmacy practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.

A conversation with Melody Hartzler, PharmD, at the 2024 National Community Pharmacists Association Annual Convention and Expo.

Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.

A conversation with David Ha, PharmD, BCIDP, at the National Community Pharmacists Association 2024 Annual Convention and Expo.

Trent Thiede, PharmD, MBA, president of PAAS National, discusses best practices that pharmacy teams can implement to proactively prevent audit issues before they arise.

At the NCPA 2024 Annual Convention and Expo, Drug Topics asked different pharmacists what they think the importance of the conference is to the independent pharmacy community.

Melody Hartzler, PharmD, discusses common metabolic roadblocks to weight loss and what tools pharmacy teams can use to identify and address them.

With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.

The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.

Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.

PBM reform legislation has progressed further in Congress than ever before.

A conversation with Erin Rexroth, director of marketing at the National Community Pharmacists Association.

A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.

The digest was released at the NCPA 2024 Annual Convention and Expo.

Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.

A conversation with Lauren Angelo, PharmD, MBA, associate dean of academic affairs and associate professor of pharmacy practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.

The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.

AJ Loiacono, co-founder and CEO of Capital RX, discusses how the National Average Drug Acquisition Cost provides accuracy and transparency for stakeholders across the drug supply chain.

David Ha, PharmD, BCIDP, discusses why pharmacies should begin offering more vaccines and how they can better market their services to the community.

The first of a 2-part presentation focused on vaccines for COVID-19, flu, RSV, and pneumococcal disease.

The cost effectiveness of biosimilar denosumab for postmenopausal osteoporosis varies significantly based on factors like adherence, subsequent therapies, and treatment duration.

Analyzing outcomes from the COVID-19, influenza, and pneumococcal vaccines, researchers explored the effectiveness and patient hesitancy surrounding each vaccine.

Research presented at AMCP Nexus 2024 underscored and explored the need for treatments that can prevent or mitigate flare-ups in patients with AD.

New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses what sessions he is looking forward to and key themes he expects to be the topic of conversation at NCPA 2024.

Posters presented at IDWeek 2024 provided new insights into the impact of COVID-19 infection and vaccination on women’s health.